# A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China

> **NCT05337189** · — · RECRUITING · sponsor: **Creative Biosciences (Guangzhou) Co., Ltd.** · enrollment: 482 (estimated)

## Conditions studied

- Bladder Cancer
- Urocystitis
- Urinary Bladder Stone
- Urothelial Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Urine DNA methylation analysis
- **PROCEDURE:** medical imaging and/or cystoscopy and/or pathological examination

## Key facts

- **NCT ID:** NCT05337189
- **Lead sponsor:** Creative Biosciences (Guangzhou) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-09
- **Primary completion:** 2025-04-15
- **Final completion:** 2025-04-30
- **Target enrollment:** 482 (ESTIMATED)
- **Last updated:** 2025-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05337189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05337189, "A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05337189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*